| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income, net | 2,212 | 1,123 | 2,879 | 1,504 |
| Net loss before provision for income taxes | -20,627 | -19,864 | -24,941 | -20,879 |
| Benefit from income taxes | -234 | 44 | 98 | -2,106 |
| Net loss | -20,393 | -19,908 | -25,039 | -18,773 |
| Unrealized gain (loss) on available-for-sale marketable securities | -1 | -249 | -88 | 1,904 |
| Comprehensive loss | -20,394 | -20,157 | -25,127 | -16,869 |
| Earnings per share, basic, total | -0.55 | -0.54 | -0.68 | -0.51 |
| Earnings per share, diluted, total | -0.55 | -0.54 | -0.68 | -0.51 |
| Weighted average number of shares outstanding, basic, total | 37,349,449 | 37,156,979 | 37,019,027 | 36,766,309 |
| Weighted average number of shares outstanding, diluted, total | 37,349,449 | 37,156,979 | 37,019,027 | 36,766,309 |
Metagenomi, Inc. (MGX)
Metagenomi, Inc. (MGX)